Literature DB >> 14587381

[Exanthematous outbreak caused by human parvovirus B19 in a school in Banderaló, Argentina].

A Alonso1, A Distefano, O Carlino, A Polito.   

Abstract

We report an exanthematic outbreak in a school of Banderaló town, located in the district of General Villegas, Buenos Aires province, Argentina. This outbreak affected 21 individuals, with a wide range of age (out of a total population of 1400). The observed clinical manifestations were exanthema and in some cases fever, asthenia, arthropathies and myalgia. The presence of specific IgM antibodies against measles, rubella and human parvovirus B19 were investigated. Analysis of IgM antibodies to parvovirus B19 by ELISA was positive in 90.8% of the cases and viremia was detected in 66.7% of the patients by nested PCR. These results indicate that human parvovirus B19 was the etiologic agent of the outbreak and they confirm its circulation in Argentina. Moreover, this study demonstrates that PCR may be useful for the study of transmission foci and of individuals with prolongued clinical manifestations. We consider that it is necessary to include the differential diagnosis of human parvovirus B19 in the surveillance of exanthematic virosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14587381

Source DB:  PubMed          Journal:  Rev Argent Microbiol        ISSN: 0325-7541            Impact factor:   1.852


  1 in total

1.  Beyond arboviruses: A multicenter study to evaluate differential diagnosis of rash diseases and acute febrile illness cases in Rio de Janeiro, Brazil.

Authors:  Arthur Daniel Rocha Alves; Jéssica Vasques Raposo; Rafaela Moraes Pereira de Sousa; Claudete Aparecida Araújo Cardoso; Pâmela Karla Simões de Freitas Costa; Julienne Martins Araújo; Sabrina Teresinha Alvim Barreiro; Clarisse da Silveira Bressan; Guilherme Amaral Calvet; Rogério Valls de Souza; Patrícia Brasil; Rita de Cássia Nasser Cubel Garcia; Marcelo Alves Pinto; Vanessa Salete de Paula; Luciane Almeida Amado
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.